Even though the medical relevance with the aforementioned cardiovascular risk factor alterations by tirzepatide are going to be assessed inside the prepared cardiovascular outcome examine SURPASS-CVOT ( "type":"clinical-demo","attrs": "textual content":"NCT04255433","term_id":"NCT04255433" NCT04255433), a pre-specified cardiovascular meta-Assessmen